Gilead Sciences, Inc. GILD NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score

78/100

6/7 Pass

SharesGrow Intrinsic Value

Gilead Sciences, Inc. (GILD) 報告總資產為 $59.02B 總負債為 $36.41B 財年 2025, 總權益為 $22.62B.

公司持有 $10.61B 現金及短期投資. 總債務為 $24.59B, 淨債務為 $17.03B. D/E比率為 1.09 (適中的).

流動比率為 1.68, 表明短期流動性強. 利息覆蓋率為 11.5x (強勁的).

本頁支持的標準:

HEALTH (83/100, Pass) — Debt-to-Equity of 1.09, current ratio of 1.68, interest coverage 11.5x — 資產負債表強勁
MOAT (90/100) — 總資產 $59.02B 和 equity $22.62B 支持公司的競爭規模
VALUE (57/100) — Debt-to-Equity 1.09 影響整體估值風險評估

SharesGrow 綜合評分: 78/100 其中 6/7 項標準通過.

SharesGrow 7-Criteria Score

78/100

SG Score

View full scorecard →

價值

57/100

Price-to-Earnings & upside

→ Valuation

✓

未來

61/100

Analyst consensus

→ Forecast

✓

過去

100/100

→ Income

✓

健康

83/100

Debt-to-Equity & liquidity

Proven by this page

✓

護城河

90/100

→ Income

✓

成長

73/100

→ Income

✓

收入

85/100

→ Income

Gilead Sciences, Inc. 資產負債表歷史

指標	FY2025	FY2024	FY2023	FY2022
總資產	$59.02B	$59B	$62.13B	$63.17B
Total Liabilities	$36.41B	$39.75B	$39.38B	$41.96B
總債務	$24.59B	$26.71B	$24.99B	$25.23B
Cash & Investments	$10.61B	$11.57B	$7.26B	$6.39B
股東權益總計	$22.62B	$19.33B	$22.83B	$21.24B